作者: Anaïs Legand , Sylvie Briand , Nikki Shindo , W Abdullah Brooks , Menno D De Jong
DOI: 10.2217/FVL.13.85
关键词:
摘要: Given the enormous estimated burden of respiratory virus infections worldwide, a substantial number research priorities exist in order to better understand their epidemiology, pathogenesis, prevention and clinical management across different populations resource settings. New therapeutics specific vaccines for noninfluenza could provide benefits reducing morbidity mortality associated with these frequent foundation responding newly emerging threats. The BRaVe Initiative is new WHO-led effort catalyze multidisciplinary on strategies prevent treat medically important goal timely integration scientific advances technical innovations into public health practice.